Comparing care models to find and manage high blood pressure after childbirth
Tests two care models for early high blood pressure after childbirth in adults.
Key facts
- Who runs it
- Yale University
- Where
- Buffalo, New Haven, and Worcester, United StatesSee the 3 sites
- Trial code
- Registry title
- Trauma-informed Approach to Timely Detection and Management of Early Postpartum Hypertension
- Status
- Recruiting
- People taking part
- 6,030 people, planned
- Started
- 12 Jun 2023
- Expected to end
- 31 Oct 2027
- Type of study
- Interventional, 3 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Remote Medical Model (RMM)
- Community Health Model (CHM)
- SoC
- Record updated
- 5 November 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for women in the first weeks after a live birth who are on Medicaid or uninsured and live in Connecticut, Massachusetts or New York. It looks at early detection and care of high blood pressure after birth.
- Age
- 18 years or older
- Sex
- Women
- Disease stage
- After delivery of one live baby, pregnancy of 24 weeks or more
Main reasons for not taking part
- Twins or more babies in the pregnancy
- Pregnancy shorter than 24 weeks, major fetal anomaly or stillbirth
- Active use of illegal drugs such as cocaine, heroin or fentanyl
- Active suicidal thoughts with intent and plan, or a known primary psychotic disorder
- Plans to move out of the state within 6 months
The registry criteria, word for word
Show all 19 criteriaShow less
Who can take part
- Delivery of singleton live birth (twins reduced to singleton or with vanishing twin syndrome prior to 14 weeks qualify)
- Postpartum
- English or Spanish speaking
- Viable pregnancy 24 weeks of gestation or above (Child can be in NICU to participate)
- Medicaid or the equivalent within each state (for example, Connecticut has Husky insurance) or uninsured
- Must living in one of the three states involved in this study (Connecticut, Massachusetts, New York) and preferably within the geographical area of each of the hospitals
Who cannot take part
- Known primary psychotic disorder (i.e. schizophrenia, or schizoaffective disorder)
- Severe medical complications that don't allow a mother to do the study effectively (for example, active treatment for cancer, dialysis etc. )
- Gestational age <24 weeks
- Multifetal pregnancy (since are they at increased risk for key outcomes)
- Known major fetal anomaly in current pregnancy or stillbirth
- Actively using illicit/illegal substances (such as cocaine, heroin and other types of illicit opiates such as fentanyl) as noted in delivery hospitalization notes
- Active suicidal ideation with intent and plan
- Plans to move out of the state within 6 months
- Incapable of consent
- Physician or provider refusal
- Patient refusal
- Incarcerated or institutionalized
- Stillbirth; Births that result in the newborn being under the care of another person or institution other than the birthing individual (e.g. adoption, state involvement) will be evaluated on an individual basis to determine if that person should be included; For participants without access to a phone, we will explore if there are options that will allow them to have access to a devise for the times when they need to communicate with the study team. If not, they will not be able to participate in the study since this study requires phone or telehealth communication with research staff and/or APPs, and CHWs depending on study phase
Where in United States
- Oishei Children's Hospital University at BuffaloBuffalo, United StatesContact: Rafael Pérez-Escamilla, PhDTaking people
- Yale New Haven HospitalNew Haven, United StatesContact: Rafael Pérez-Escamilla, PhD (principal investigator)Taking people
- University of Massachusetts Memorial HealthWorcester, United StatesContact: Rafael Pérez-Escamilla, PhDTaking people
About the trial
What the trial wants to find out
The investigators primary project goal is to improve clinical outcomes, including mental health outcomes, among postpartum at-risk women experiencing health disparities by increasing awareness, detection, and timely care of postpartum hypertension, mental health and cardiovascular complications. The investigators will accomplish this by comparing the effectiveness of two multi-component multi-level healthcare delivery models focused on early detection and control of postpartum hypertension and the social and mental health factors known to impact maternal outcomes, with the current standard of care and with each other.
The 3 groups in the trial
- Standard of Care (SoC)Existing treatment, for comparison
Standard of Care for Postpartum Hypertension
Treatment: SoC
- Remote Medical Model (RMM)Treatment being tested
Includes SoC plus RMM
Treatment: Remote Medical Model (RMM) and SoC
- Community Health Model (CHM)Treatment being tested
Includes SoC, RMM plus CHM
Treatment: Remote Medical Model (RMM), Community Health Model (CHM), and SoC
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Community-based, Family-centered, Trauma-informed Approach to Timely Detection and Management of Early Postpartum Hypertension
- Plain-language title
- Comparing care models to find and manage high blood pressure after childbirthGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 5 November 2026